CLINICAL_TRIALS
trial_result
· 2017-03-29
Clinical Trial Update: A Study of Pregnenolone in the Treatment of Individuals With Autism [Phase 2]
Summary
A Phase 2 study evaluating pregnenolone for autism spectrum disorder has completed; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Autistic Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-03-29